Business
ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news
It looks set to be another positive day of trade for the S&P/ASX 200 Index (ASX: XJO) on Tuesday after a third COVID-19 vaccine candidate was shown to be effective.
At the time of writing, SPI futures are pointing to the ASX opening the day 31 points or 0.5% higher this morning.
What is the new vaccine candidate?
Overnight British pharmaceutical giant AstraZeneca revealed that data from an interim analysis of clinical trials showed that its vaccine, AZD1222, had an average efficacy of 70% in protecting against COVID-19.
This follows recent updates by both Pfizer and Moderna which showed that their vaccines are 95% effective against the virus.
While 70% might not sound amazing, it is worth noting that the AstraZeneca vaccine,…
-
Noosa News7 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General18 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General21 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Business20 hours ago3 ASX 200 shares that could be top buys for growth